Form D · Pharmaceuticals
Affigen Holdings LLC
Saint Louis, MO · CIK 0001698744
Offering snapshot reported Feb 23, 2017 · SEC filing
- Reported sold
- $17M Offering amount: $17M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2017 | Initial | $17,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-281240
Limited Liability Company Units
Source: Form D, filed Feb 23, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Black Beret Life Sciences | Director |
| Forrest T Cox | Executive, Promoter |
| Jonathan P Feldmann | Executive, Promoter |
| Frameshift Affinity Holdings Llc | Director |
| Carlos F Santos | Executive, Promoter |
| David J States | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
20 S Sarah Street
Saint Louis, MO, 63108
Saint Louis, MO, 63108